+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Protein Engineering Market - Global Forecast 2026-2032- Product Image
Protein Engineering Market - Global Forecast 2026-2032- Product Image
Sale

Protein Engineering Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5532963
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Protein Engineering Market is projected to reach USD 4.98 Billion in 2026. It is expected to continue growing at a CAGR of 11.08%, reaching USD 9.51 Billion by 2032.

Protein engineering is moving from a specialized research capability to a core platform for biopharmaceuticals, industrial biotechnology, diagnostics, agriculture, food technology, and sustainable materials. The field combines rational design, directed evolution, synthetic biology, and computational modeling to create proteins with improved affinity, stability, specificity, expression yield, and manufacturability.

Demand is supported by established evidence across approved recombinant therapeutics, monoclonal antibodies, enzymes, vaccines, and diagnostic reagents. As organizations seek faster discovery cycles and more resilient biomanufacturing, protein engineering is increasingly tied to artificial intelligence, automation, high-throughput screening, structural biology, and quality-by-design strategies.

Transformative Shifts in the Protein Engineering Landscape

The protein engineering landscape is being reshaped by high-throughput DNA synthesis, next-generation sequencing, automated liquid handling, microfluidics, and cell-free expression systems. These tools allow teams to test larger variant libraries and shorten the design-build-test-learn cycle while improving reproducibility.

Commercial priorities are also shifting. Biopharma teams are engineering antibodies, enzymes, cytokines, fusion proteins, and gene-editing components for better safety, potency, half-life, and durability, while industrial users are adopting engineered enzymes to lower energy use, reduce solvent dependence, improve process selectivity, and support circular manufacturing models.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is now a major accelerator for structure prediction, sequence optimization, de novo protein design, and developability assessment. DeepMind and EMBL-EBI’s AlphaFold Protein Structure Database has made more than 200 million predicted protein structures available, strengthening global access to structural biology resources and supporting faster hypothesis generation.

The impact is cumulative rather than standalone: AI improves protein modeling and variant prioritization, but wet-lab validation, biophysical characterization, immunogenicity evaluation, toxicity assessment, and regulatory documentation remain essential. Leaders are integrating machine learning with validated datasets, laboratory automation, and governance controls to reduce failed experiments and improve translation from in silico design to manufacturable products.

Key Regional Insights

North America remains a leading region for protein engineering due to strong U.S. and Canadian biopharma ecosystems, university spinouts, venture funding, FDA experience, NIH-supported biomedical research, and advanced contract development and manufacturing capacity. Europe benefits from EMA-aligned regulatory depth, public research funding, established pharmaceutical clusters, and translational science networks across Germany, the United Kingdom, France, Italy, and Spain.

Asia-Pacific is expanding through China’s biotech scale-up, India’s biologics and vaccine manufacturing base, Japan’s precision science infrastructure, South Korea’s biologics CDMO strength, and Australia’s translational research networks. Latin America is led by Brazil and Mexico in public health manufacturing, clinical demand, and regional supply-chain integration. The Middle East, especially Gulf economies, is investing in healthcare localization, genomics, and precision medicine infrastructure, while Africa is building vaccine and biologics capacity through public-private initiatives supported by international health agencies and regional manufacturing programs.

Key Group Insights

ASEAN markets are gaining relevance as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines expand biomedical research, clinical infrastructure, biotechnology incentives, and manufacturing capabilities. The GCC is using national healthcare and economic diversification strategies to attract biologics production, precision medicine investment, genomic programs, and regional life science partnerships.

The European Union provides a large regulated environment supported by Horizon Europe funding, EMA guidance, cross-border research networks, and harmonized quality standards. BRICS countries contribute scale in manufacturing, patient populations, clinical research, and public-sector biotechnology. G7 economies remain central to advanced discovery, intellectual property creation, regulatory science, and high-value biomanufacturing, while NATO countries increasingly view biosecurity, supply-chain resilience, pathogen preparedness, and dual-use risk management as strategic priorities for protein engineering and synthetic biology.

Key Country Insights

The United States leads through NIH-funded science, FDA regulatory maturity, venture-backed biotechnology, clinical trial density, and deep biomanufacturing capacity, while Canada offers strong academic clusters, biologics expertise, and translational research programs. Mexico supports regional manufacturing integration and nearshore supply-chain opportunities, and Brazil contributes public vaccine institutions, biopharma demand, clinical research capacity, and long-standing public health manufacturing experience.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine pharmaceutical manufacturing, academic excellence, clinical networks, regulatory experience, and skilled bioprocessing talent, while Russia maintains domestic biotechnology capabilities and scientific infrastructure. China is scaling discovery and manufacturing under NMPA oversight; India is a major vaccine, biosimilar, and biologics producer; Japan emphasizes quality, precision regulation, and advanced life sciences; Australia supports translational medicine and clinical development; and South Korea is a global biologics CDMO and biosimilars hub supported by government-backed biomanufacturing ambitions.

Actionable Recommendations for Industry Leaders

Industry leaders should connect AI-enabled protein design with automated experimentation, robust assay design, early developability screening, and manufacturability assessment. Investment should prioritize validated datasets, protein expression platforms, analytical characterization, formulation science, and scalable purification processes rather than isolated algorithmic tools.

Organizations should also strengthen regulatory readiness, intellectual property strategy, supplier redundancy, cybersecurity, and biosecurity oversight. Partnerships with academic laboratories, CDMOs, cloud laboratories, standards bodies, and regional innovation agencies can accelerate access to talent, infrastructure, specialized assays, and market-specific compliance knowledge.

Research Methodology

This executive summary is grounded in publicly available and verifiable sources, including regulatory agency materials, peer-reviewed scientific literature, patent landscapes, clinical trial registries, public funding announcements, and recognized institutional databases such as FDA, EMA, NIH, WHO, OECD, WIPO, ClinicalTrials.gov, and EMBL-EBI resources.

Insights were triangulated across scientific, commercial, regulatory, and regional indicators. Claims were framed conservatively to avoid unsupported market sizing, market share, or forecasting, and qualitative conclusions were derived from observable technology adoption, approved biologics activity, manufacturing investment, public research programs, and documented advances in computational protein science.

Conclusion

Protein engineering is becoming a strategic foundation for next-generation therapeutics, sustainable biomanufacturing, advanced diagnostics, food system innovation, and resilient health systems. The combination of AI, automation, synthetic biology, structural biology, and validated wet-lab workflows is expanding what organizations can design, test, optimize, and manufacture.

Success will depend on disciplined execution: high-quality data, experimentally confirmed performance, scalable production, regulatory alignment, biosecurity governance, and responsible innovation. Organizations that integrate these capabilities early will be better positioned to capture value across biopharma, industrial enzymes, food systems, precision medicine, and sustainable biotechnology.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Protein Engineering Market, by Type
7.1. Introduction
7.2. Enzyme Engineering
7.2.1. Industrial Enzymes
7.2.2. Medical Enzymes
7.2.3. Diagnostic Enzymes
7.3. Antibody Engineering
7.3.1. Monoclonal
7.3.2. Polyclonal
7.4. Protein Design
7.4.1. De novo Protein Design
7.4.2. Rational Protein Design
7.5. Protein Optimization
7.6. Protein Modification
7.6.1. Glycoengineering
7.6.2. PEGylation
8. Protein Engineering Market, by Technology Platform
8.1. Introduction
8.2. Directed Evolution
8.2.1. DNA Shuffling
8.2.2. Error Prone Pcr
8.3. Gene Synthesis
8.3.1. Gene Fragment Synthesis
8.3.2. Synthetic Gene Assembly
8.4. Site Directed Mutagenesis
8.4.1. Random Mutagenesis
8.4.2. Rational Mutagenesis
9. Protein Engineering Market, by Protein Type
9.1. Introduction
9.2. Insulin
9.3. Monoclonal Antibodies
9.4. Vaccines
9.5. Enzymes
9.6. Hormones
9.7. Cytokines
10. Protein Engineering Market, by Host Organism
10.1. Introduction
10.2. Prokaryotic Systems
10.3. Eukaryotic Systems
10.4. Synthetic Hosts
11. Protein Engineering Market, by Application
11.1. Introduction
11.2. Agricultural Biotechnology
11.2.1. Crop Improvement
11.2.2. Pest Resistance
11.3. Industrial Enzyme Engineering
11.3.1. Biofuels
11.3.2. Detergents
11.4. Therapeutic Protein Development
11.4.1. Monoclonal Antibodies
11.4.2. Vaccines
12. Protein Engineering Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Biotechnology Companies
12.4. Contract Research Organizations
12.5. Pharmaceutical Companies
13. Protein Engineering Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Protein Engineering Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Protein Engineering Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Absci Corp
17.2. Abzena Ltd
17.3. Adimab LLC
17.4. Agilent Technologies Inc
17.5. Amgen Inc
17.6. Arzeda Corp
17.7. BigHat Biosciences Inc
17.8. Bio-Rad Laboratories Inc
17.9. Bruker Corporation
17.10. Charles River Laboratories International Inc
17.11. Codexis Inc
17.12. Danaher Corporation
17.13. Evotec SE
17.14. Genentech Inc
17.15. Generate Biomedicines Inc
17.16. GenScript Biotech Corporation
17.17. Ginkgo Bioworks Inc
17.18. Lonza Group Ltd
17.19. Merck KGaA
17.20. Novo Nordisk A/S
17.21. Nuclera Nucleics Ltd
17.22. Profluent Bio Inc
17.23. ProteinQure Inc
17.24. Sino Biological Inc
17.25. Sutro Biopharma Inc
17.26. Thermo Fisher Scientific Inc
17.27. Twist Bioscience Corp
17.28. Waters Corp
17.29. WuXi AppTec Co Ltd
17.30. Zymeworks Inc
18. Key Experts
List of Figures
FIGURE 1. Global Protein Engineering Market, Years Considered for the Study
FIGURE 2. Global Protein Engineering Market, Research Design
FIGURE 3. Global Protein Engineering Market, Research Framework
FIGURE 4. Global Protein Engineering Market, Data Triangulation
FIGURE 5. Global Protein Engineering Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Protein Engineering Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Protein Engineering Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Protein Engineering Market Size, by Technology Platform, 2025 vs 2032 (%)
FIGURE 9. Global Protein Engineering Market Size, by Technology Platform, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Protein Engineering Market Size, by Protein Type, 2025 vs 2032 (%)
FIGURE 11. Global Protein Engineering Market Size, by Protein Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Protein Engineering Market Size, by Host Organism, 2025 vs 2032 (%)
FIGURE 13. Global Protein Engineering Market Size, by Host Organism, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Protein Engineering Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Protein Engineering Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Protein Engineering Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Protein Engineering Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Protein Engineering Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Protein Engineering Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Protein Engineering Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Protein Engineering Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Protein Engineering Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Protein Engineering Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Protein Engineering Market Segmentation & Coverage
TABLE 2. Global Protein Engineering Market Size, 2017-2032 (USD Million)
TABLE 3. Global Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Enzyme Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Enzyme Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Enzyme Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Industrial Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Industrial Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Industrial Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Medical Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Medical Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Medical Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Diagnostic Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Diagnostic Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Diagnostic Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Antibody Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Antibody Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Antibody Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Monoclonal Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Monoclonal Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Monoclonal Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Polyclonal Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Polyclonal Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Polyclonal Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Protein Design Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Protein Design Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Protein Design Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global De novo Protein Design Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global De novo Protein Design Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global De novo Protein Design Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Rational Protein Design Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Rational Protein Design Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Rational Protein Design Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Protein Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Protein Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Protein Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Protein Modification Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Protein Modification Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Protein Modification Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Glycoengineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Glycoengineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Glycoengineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global PEGylation Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global PEGylation Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global PEGylation Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 47. Global Directed Evolution Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Directed Evolution Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Directed Evolution Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global DNA Shuffling Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global DNA Shuffling Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global DNA Shuffling Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Error Prone Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Error Prone Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Error Prone Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Gene Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Gene Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Gene Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Gene Fragment Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Gene Fragment Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Gene Fragment Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Synthetic Gene Assembly Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Synthetic Gene Assembly Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Synthetic Gene Assembly Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Site Directed Mutagenesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Site Directed Mutagenesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Site Directed Mutagenesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Random Mutagenesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Random Mutagenesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Random Mutagenesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Rational Mutagenesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Rational Mutagenesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Rational Mutagenesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 75. Global Insulin Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Insulin Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Insulin Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Hormones Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Hormones Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Hormones Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Cytokines Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Cytokines Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Cytokines Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 94. Global Prokaryotic Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Prokaryotic Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Prokaryotic Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Eukaryotic Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Eukaryotic Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Eukaryotic Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Synthetic Hosts Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Synthetic Hosts Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Synthetic Hosts Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Global Agricultural Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Agricultural Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Agricultural Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Crop Improvement Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Crop Improvement Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Crop Improvement Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Pest Resistance Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Pest Resistance Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Pest Resistance Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Industrial Enzyme Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Industrial Enzyme Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Industrial Enzyme Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Biofuels Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Biofuels Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Biofuels Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Detergents Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Detergents Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Detergents Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Therapeutic Protein Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Therapeutic Protein Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Therapeutic Protein Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Monoclonal Antibodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Monoclonal Antibodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Monoclonal Antibodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Protein Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Protein Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. North America Protein Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. North America Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 164. North America Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 165. North America Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 166. North America Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 167. North America Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 168. North America Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 169. North America Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 170. North America Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 171. North America Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 172. North America Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 173. North America Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 174. North America Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. North America Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 176. North America Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 177. North America Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 178. North America Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Latin America Protein Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Latin America Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 181. Latin America Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 182. Latin America Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 183. Latin America Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 184. Latin America Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 185. Latin America Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 186. Latin America Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 187. Latin America Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 188. Latin America Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 189. Latin America Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 190. Latin America Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 191. Latin America Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Latin America Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 193. Latin America Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 194. Latin America Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 195. Latin America Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Europe Protein Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Europe Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 198. Europe Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 199. Europe Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 200. Europe Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 201. Europe Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 202. Europe Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 203. Europe Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 204. Europe Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 205. Europe Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 206. Europe Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 207. Europe Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 208. Europe Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Europe Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 210. Europe Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 211. Europe Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 212. Europe Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Middle East Protein Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 214. Middle East Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 215. Middle East Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 216. Middle East Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 217. Middle East Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 218. Middle East Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 219. Middle East Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 220. Middle East Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 221. Middle East Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 222. Middle East Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 223. Middle East Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 224. Middle East Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 225. Middle East Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Middle East Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 227. Middle East Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 228. Middle East Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 229. Middle East Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Africa Protein Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 231. Africa Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 232. Africa Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 233. Africa Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 234. Africa Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 235. Africa Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 236. Africa Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 237. Africa Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 238. Africa Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 239. Africa Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 240. Africa Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 241. Africa Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 242. Africa Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. Africa Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 244. Africa Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 245. Africa Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 246. Africa Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. Global Protein Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 248. ASEAN Protein Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 249. ASEAN Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 250. ASEAN Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 251. ASEAN Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 252. ASEAN Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 253. ASEAN Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 254. ASEAN Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 255. ASEAN Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 256. ASEAN Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 257. ASEAN Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 258. ASEAN Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 259. ASEAN Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 260. ASEAN Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. ASEAN Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 262. ASEAN Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 263. ASEAN Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 264. ASEAN Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. GCC Protein Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 266. GCC Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 267. GCC Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 268. GCC Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 269. GCC Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 270. GCC Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 271. GCC Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 272. GCC Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 273. GCC Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 274. GCC Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 275. GCC Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 276. GCC Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 277. GCC Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. GCC Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 279. GCC Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 280. GCC Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 281. GCC Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. European Union Protein Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 283. European Union Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 284. European Union Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 285. European Union Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 286. European Union Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 287. European Union Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 288. European Union Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 289. European Union Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 290. European Union Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 291. European Union Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 292. European Union Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 293. European Union Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 294. European Union Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. European Union Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 296. European Union Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 297. European Union Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 298. European Union Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. BRICS Protein Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 300. BRICS Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 301. BRICS Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 302. BRICS Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 303. BRICS Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 304. BRICS Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 305. BRICS Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 306. BRICS Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 307. BRICS Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 308. BRICS Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 309. BRICS Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 310. BRICS Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 311. BRICS Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 312. BRICS Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 313. BRICS Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 314. BRICS Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 315. BRICS Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. G7 Protein Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 317. G7 Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 318. G7 Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 319. G7 Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 320. G7 Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 321. G7 Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 322. G7 Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 323. G7 Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 324. G7 Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 325. G7 Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 326. G7 Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 327. G7 Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 328. G7 Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 329. G7 Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 330. G7 Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 331. G7 Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 332. G7 Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. NATO Protein Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 334. NATO Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 335. NATO Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 336. NATO Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (USD Million)
TABLE 337. NATO Protein Engineering Market Size, by Protein Design, 2017-2032 (USD Million)
TABLE 338. NATO Protein Engineering Market Size, by Protein Modification, 2017-2032 (USD Million)
TABLE 339. NATO Protein Engineering Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 340. NATO Protein Engineering Market Size, by Directed Evolution, 2017-2032 (USD Million)
TABLE 341. NATO Protein Engineering Market Size, by Gene Synthesis, 2017-2032 (USD Million)
TABLE 342. NATO Protein Engineering Market Size, by Site Directed Mutagenesis, 2017-2032 (USD Million)
TABLE 343. NATO Protein Engineering Market Size, by Protein Type, 2017-2032 (USD Million)
TABLE 344. NATO Protein Engineering Market Size, by Host Organism, 2017-2032 (USD Million)
TABLE 345. NATO Protein Engineering Market Size, by Application, 2017-2032 (USD Million)
TABLE 346. NATO Protein Engineering Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
TABLE 347. NATO Protein Engineering Market Size, by Industrial Enzyme Engineering, 2017-2032 (USD Million)
TABLE 348. NATO Protein Engineering Market Size, by Therapeutic Protein Development, 2017-2032 (USD Million)
TABLE 349. NATO Protein Engineering Market Size, by End User, 2017-2032 (USD Million)
TABLE 350. Global Protein Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 351. United States Protein Engineering Market Size, 2017-2032 (USD Million)
TABLE 352. United States Protein Engineering Market Size, by Type, 2017-2032 (USD Million)
TABLE 353. United States Protein Engineering Market Size, by Enzyme Engineering, 2017-2032 (USD Million)
TABLE 354. United States Protein Engineering Market Size, by Antibody Engineering, 2017-2032 (US

Companies Mentioned

  • Absci Corp
  • Abzena Ltd
  • Adimab LLC
  • Agilent Technologies Inc
  • Amgen Inc
  • Arzeda Corp
  • BigHat Biosciences Inc
  • Bio-Rad Laboratories Inc
  • Bruker Corporation
  • Charles River Laboratories International Inc
  • Codexis Inc
  • Danaher Corporation
  • Evotec SE
  • Genentech Inc
  • Generate Biomedicines Inc
  • GenScript Biotech Corporation
  • Ginkgo Bioworks Inc
  • Lonza Group Ltd
  • Merck KGaA
  • Novo Nordisk A/S
  • Nuclera Nucleics Ltd
  • Profluent Bio Inc
  • ProteinQure Inc
  • Sino Biological Inc
  • Sutro Biopharma Inc
  • Thermo Fisher Scientific Inc
  • Twist Bioscience Corp
  • Waters Corp
  • WuXi AppTec Co Ltd
  • Zymeworks Inc

Table Information

Report AttributeDetails
No. of Pages184
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.98 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.51 Billion
Compound Annual Growth Rate11.0%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Lab Automation in Protein Engineering Market - Global Forecast 2026-2032 - Product Image

Lab Automation in Protein Engineering Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Protein Engineering - Global Strategic Business Report - Product Image

Protein Engineering - Global Strategic Business Report

  • Report
  • 351 Pages
  • Global
From
Protein Engineering Market Size, Share, Trends and Forecast by Product & Services, Protein Type, Technology, End User and Region, 2026-2034 - Product Image

Protein Engineering Market Size, Share, Trends and Forecast by Product & Services, Protein Type, Technology, End User and Region, 2026-2034

  • Report
  • 140 Pages
  • Global
From
Protein Engineering - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Protein Engineering - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 134 Pages
  • Global
From
AI Protein Engineering - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

AI Protein Engineering - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 140 Pages
  • Global
From

About the Market

Protein engineering is a field of biotechnology that involves the manipulation of proteins to create new or improved proteins with desired properties. It is closely related to genomics, which is the study of the structure, function, and evolution of genomes. Protein engineering is used to create proteins with specific functions, such as enzymes, antibodies, and hormones. It is also used to modify existing proteins to improve their properties, such as stability, solubility, and activity. Protein engineering is used in a variety of industries, including pharmaceuticals, biotechnology, and food production. It is used to develop new drugs, create new food products, and improve existing products. It is also used in research to study the structure and function of proteins. Companies in the protein engineering market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.